Rump P, Niessen RC, Verbruggen KT, Brouwer OF, de Raad M, Hordijk R. A novel mutation in MED12 causes FG syndrome (Opitz–Kaveggia syndrome).
Opitz–Kaveggia syndrome is a rare X-linked multiple congenital anomalies and intellectual disability disorder caused by the recurrent p.R961W mutation in the MED12 gene. Twenty-three affected males from 10 families with this mutation in the MED12 gene have been described so far. Here we report on a new family with three affected cousins, in which we identified a novel MED12 mutation (p.G958E). This is the first demonstration that other mutations in this gene can also lead to Opitz–Kaveggia syndrome. The clinical phenotype of these three new cases is reviewed in detail and compared with the previous reported cases.
"Exclusion criteria include female sex, lack of intellectual disability, and autosomal patterns of inheritance. One family who met these criteria was found to carry a novel p. G958E mutation in MED12, with mild manifestations in carrier females [Rump et al., 2011]. "
[Show abstract][Hide abstract] ABSTRACT: Uterine leiomyomas, or fibroids, are benign tumors that affect millions of women worldwide and that can cause considerable
morbidity. To study the genetic basis of this tumor type, we examined 18 uterine leiomyomas derived from 17 different patients
by exome sequencing and identified tumor-specific mutations in the mediator complex subunit 12 (MED12) gene in 10. Through analysis of 207 additional tumors, we determined that MED12 is altered in 70% (159 of 225) of tumors from a total of 80 patients. The Mediator complex is a 26-subunit transcriptional
regulator that bridges DNA regulatory sequences to the RNA polymerase II initiation complex. All mutations resided in exon
2, suggesting that aberrant function of this region of MED12 contributes to tumorigenesis.
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.